Lineberger Comprehensive Cancer Center

Lineberger Comprehensive Cancer Center
Name	Lineberger Comprehensive Cancer Center
Established	1975
Type	Academic medical center
Affiliation	University of North Carolina at Chapel Hill
City	Chapel Hill, North Carolina
Country	United States

Lineberger Comprehensive Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center at the University of North Carolina at Chapel Hill. As a cornerstone of the state's biomedical research enterprise, it integrates laboratory discovery, translational science, and population-based research to advance the understanding and treatment of cancer. The center's mission encompasses pioneering research, multidisciplinary patient care, and the education of future leaders in oncology.

History

The center traces its origins to 1975 when it was founded as the UNC Cancer Research Center by Dr. Joseph S. Pagano, a pioneering virologist. Its early work focused significantly on the viral origins of cancer, building upon discoveries related to the Epstein–Barr virus. In 1990, following a generous endowment from the Lineberger family, the center was renamed and achieved its prestigious Comprehensive Cancer Center designation from the National Cancer Institute. This period coincided with major expansions, including the opening of the North Carolina Cancer Hospital in 2009, which consolidated clinical care and research. Throughout its history, it has been integral to statewide initiatives like the University of North Carolina Health system and collaborations with other institutions such as the Duke University School of Medicine.

Research programs

Scientific inquiry is organized into several interdisciplinary research programs that bridge basic and clinical sciences. The center's programs include Cancer Cell Biology, which investigates fundamental mechanisms of carcinogenesis and metastasis; Immunology, focusing on harnessing the immune system against tumors; and Cancer Genetics, exploring hereditary risk factors and genomic drivers. Additional programs in Translational Oncology and Cancer Prevention and Control work to move discoveries from the laboratory to the clinic and to address disparities through studies in populations. These efforts are supported by shared core facilities in areas like genomics, biostatistics, and animal models, fostering collaboration across departments at the University of North Carolina at Chapel Hill and with partners like the National Institutes of Health.

Clinical care

Patient care is delivered through the multidisciplinary teams at the North Carolina Cancer Hospital, the center's clinical home. Specialists in medical oncology, radiation oncology, surgical oncology, and supportive care collaborate to create individualized treatment plans. The center offers access to a wide portfolio of clinical trials, including early-phase studies developed from its own research, providing novel therapies for cancers such as breast cancer, leukemia, and melanoma. Its network extends across the state through the University of North Carolina Health system and affiliations with community hospitals, aiming to improve access to advanced cancer care. Supportive services, including psychosocial oncology and survivorship programs, address the comprehensive needs of patients and families.

Education and training

The center is deeply committed to training the next generation of cancer researchers and clinicians. It supports numerous fellowships and training grants from organizations like the National Institutes of Health and the American Cancer Society. Trainees, including postdoctoral fellows and clinical residents from the UNC School of Medicine, engage in mentored research across the spectrum of cancer science. Educational programs also extend to graduate students in the UNC Gillings School of Global Public Health and the UNC Eshelman School of Pharmacy, emphasizing interdisciplinary approaches. Continuing medical education for practicing oncologists and community outreach initiatives further its educational mission across North Carolina.

Notable achievements

Researchers have made seminal contributions to oncology, including pioneering studies on the role of human papillomavirus in cervical cancer and the development of liquid biopsy technologies for cancer detection. The center played a key role in the development and clinical testing of proteasome inhibitors for treating multiple myeloma. Its population scientists have led landmark studies on cancer disparities, particularly in African American and rural communities, influencing national screening guidelines. The center's investigators have been recognized with numerous honors, including membership in the National Academy of Sciences and awards from the American Association for Cancer Research.

Leadership and organization

The center is led by a director who oversees its research, clinical, and educational missions, reporting to the leadership of the UNC School of Medicine and the broader University of North Carolina at Chapel Hill. Scientific direction is guided by associate directors who lead specific areas such as basic research, clinical translation, and population sciences. Governance involves external advisory boards, including a National Cancer Institute-appointed board, and strong community engagement through a patient advocacy council. Its organizational structure is designed to foster collaboration across dozens of academic departments and to maintain its status as a premier Comprehensive Cancer Center.

Category:Cancer centers in the United States Category:University of North Carolina at Chapel Hill Category:Medical and health organizations based in North Carolina Category:1975 establishments in North Carolina